RecruitingNot ApplicableNCT07238478

JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of JDS-HF3.0 in Menopause Related Quality of Life Outcomes in Postmenopausal Women

Sponsor

Bonafide Health

Enrollment

250 participants

Start Date

May 14, 2025

Study Type

INTERVENTIONAL

Conditions

Night Sweats Hot Flashes Joint Pain Vasomotor Symptoms Joint Discomfort Joint Pain, Stiffness, Function Hot Flash

Summary

The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for 12 weeks can reduce the severity and frequency of menopause-related symptoms.

Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying JDS-HF3.0 and Placebo for people with hot flash, hot flashes, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 50 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.